Assessment of quality of life in children with peanut allergy

Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐...

Full description

Saved in:
Bibliographic Details
Published inPediatric allergy and immunology Vol. 14; no. 5; pp. 378 - 382
Main Authors Avery, Natalie J., King, Rosemary M., Knight, Susan, Hourihane, Jonathan O'B.
Format Journal Article
LanguageEnglish
Published Oxford, UK Munksgaard International Publishers 01.10.2003
Blackwell
Subjects
Online AccessGet full text
ISSN0905-6157
1399-3038
DOI10.1034/j.1399-3038.2003.00072.x

Cover

Loading…
Abstract Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐dependent diabetes mellitus (IDDM) was measured using two disease‐specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24‐h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p≤0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.
AbstractList Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.
Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.
Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐dependent diabetes mellitus (IDDM) was measured using two disease‐specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24‐h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p≤0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.
Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p less than or equal to 0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.
Author Knight, Susan
Hourihane, Jonathan O'B.
King, Rosemary M.
Avery, Natalie J.
Author_xml – sequence: 1
  givenname: Natalie J.
  surname: Avery
  fullname: Avery, Natalie J.
  organization: Division of Infection Inflammation and Repair, University of Southampton
– sequence: 2
  givenname: Rosemary M.
  surname: King
  fullname: King, Rosemary M.
  organization: Wellcome Trust Clinical Research Facility
– sequence: 3
  givenname: Susan
  surname: Knight
  fullname: Knight, Susan
  organization: Psychology Department, Southampton University Hospitals NHS Trust, Southampton, UK
– sequence: 4
  givenname: Jonathan O'B.
  surname: Hourihane
  fullname: Hourihane, Jonathan O'B.
  organization: Division of Infection Inflammation and Repair, University of Southampton
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15230607$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/14641608$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1v0zAUhi00xLrBX0C5gbtkx_FXIgFSVY1tooJp2sSldeI6zMVNOjvR2n9PsnZF4mZc-Uh-ntc6fk_IUdM2lpCEQkaB8bNlRllZpgxYkeUALAMAlWebV2RyuDgiEyhBpJIKdUxOYlwCUMUkfUOOKZecSigm5PM0RhvjyjZd0tbJQ4_eddtx9K62iWsSc-_8ItgmeXTdfbK22PRdgt7b8Gv7lryu0Uf7bn-ekruv57ezy3T-4-JqNp2nhkuWpzVFKaXNucCK5orVFYqSAkdj0CxqVYKilitRgbFAaZXni1LUBTNYohSI7JR83OWuQ_vQ29jplYvGeo-NbfuoFeWUDzu9CNKSM84KNYDv92BfrexCr4NbYdjq558ZgA97AKNBXwdsjIt_OZEzkDAGfdlxJrQxBltr4zrsXNt0AZ3XFPRYmV7qsRk9NqPHyvRTZXozBBT_BBzeeFn9tFMfnbfb__b09fRqGAY93ekudnZz0DH81lIxJfTP7xf6ejYvvs3Fjb5lfwDSl7rm
CitedBy_id crossref_primary_10_1016_j_jaip_2021_05_020
crossref_primary_10_1097_ACI_0000000000000271
crossref_primary_10_1111_j_1399_3038_2009_00929_x
crossref_primary_10_1111_pai_14119
crossref_primary_10_1016_j_jaci_2020_06_028
crossref_primary_10_1111_j_1398_9995_2009_02121_x
crossref_primary_10_1016_j_jaip_2020_03_016
crossref_primary_10_1111_j_1467_9930_2005_00210_x
crossref_primary_10_1111_pai_12176
crossref_primary_10_1007_s11136_012_0295_3
crossref_primary_10_1111_apa_16937
crossref_primary_10_1007_s00103_016_2368_x
crossref_primary_10_1159_000539113
crossref_primary_10_1111_j_1399_3038_2010_00994_x
crossref_primary_10_1007_s11882_017_0708_z
crossref_primary_10_3389_fimmu_2020_599637
crossref_primary_10_1016_j_jpeds_2017_04_055
crossref_primary_10_1177_183693911203700209
crossref_primary_10_1371_journal_pone_0055293
crossref_primary_10_1007_s00112_020_01094_5
crossref_primary_10_1016_S1081_1206_10_60142_1
crossref_primary_10_1111_cea_14268
crossref_primary_10_1097_ACI_0000000000000269
crossref_primary_10_1186_2045_7022_4_30
crossref_primary_10_3390_children8060497
crossref_primary_10_1111_pai_12060
crossref_primary_10_3390_children7060050
crossref_primary_10_1016_j_jaci_2010_04_003
crossref_primary_10_1111_pai_14106
crossref_primary_10_1007_s40629_014_0029_x
crossref_primary_10_1517_14728214_9_2_257
crossref_primary_10_1016_j_iac_2011_02_008
crossref_primary_10_1097_ACI_0b013e3283464cf0
crossref_primary_10_1111_cea_13727
crossref_primary_10_1111_pai_12845
crossref_primary_10_2217_imt_2020_0123
crossref_primary_10_1111_all_14414
crossref_primary_10_1016_S2352_4642_17_30041_X
crossref_primary_10_1007_s40521_022_00320_7
crossref_primary_10_1097_MOP_0000000000000684
crossref_primary_10_1111_j_1365_2222_2010_03454_x
crossref_primary_10_1089_ped_2016_0698
crossref_primary_10_1016_j_waojou_2021_100550
crossref_primary_10_1080_1744666X_2024_2315221
crossref_primary_10_1111_cea_13163
crossref_primary_10_1016_j_jpeds_2018_07_091
crossref_primary_10_1186_s13601_017_0156_9
crossref_primary_10_33808_clinexphealthsci_1589757
crossref_primary_10_2147_JAA_S290915
crossref_primary_10_1542_peds_2011_0204
crossref_primary_10_33590_emjallergyimmunol_10312276
crossref_primary_10_1111_cea_13719
crossref_primary_10_1007_BF03405155
crossref_primary_10_1586_erp_10_44
crossref_primary_10_1111_all_14666
crossref_primary_10_1111_j_1399_3038_2012_01310_x
crossref_primary_10_1186_s13223_020_00481_7
crossref_primary_10_1016_j_anai_2010_09_006
crossref_primary_10_1177_1359105315579798
crossref_primary_10_1007_s11882_019_0894_y
crossref_primary_10_3390_nu13072357
crossref_primary_10_1111_imr_13375
crossref_primary_10_1016_j_jaip_2016_09_005
crossref_primary_10_1111_cea_14241
crossref_primary_10_1186_2045_7022_3_41
crossref_primary_10_1007_s00281_012_0323_y
crossref_primary_10_1016_S1081_1206_10_60903_9
crossref_primary_10_3390_children2040439
crossref_primary_10_1016_j_iac_2019_09_006
crossref_primary_10_1080_09603120500062052
crossref_primary_10_3390_nu12051207
crossref_primary_10_1016_j_pcl_2011_02_007
crossref_primary_10_1111_pai_12742
crossref_primary_10_1586_14737159_2015_1041927
crossref_primary_10_1111_j_1365_2222_2010_03586_x
crossref_primary_10_1016_j_pcl_2011_02_003
crossref_primary_10_1016_j_iac_2011_11_005
crossref_primary_10_1177_1742395311411591
crossref_primary_10_1007_s11882_008_0033_7
crossref_primary_10_1016_j_appet_2011_06_007
crossref_primary_10_1111_pai_12504
crossref_primary_10_1348_135910706X173278
crossref_primary_10_1111_j_1365_2222_2011_03711_x
crossref_primary_10_1111_j_1365_2222_2011_03927_x
crossref_primary_10_7721_chilyoutenvi_24_3_0102
crossref_primary_10_1111_j_1365_2222_2007_02726_x
crossref_primary_10_1093_jpepsy_jsv058
crossref_primary_10_1111_pai_12074
crossref_primary_10_1016_j_aller_2013_09_006
crossref_primary_10_1016_j_anai_2020_01_016
crossref_primary_10_1016_j_pcl_2015_07_016
crossref_primary_10_1111_j_1399_3038_2004_00174_x
crossref_primary_10_3389_fimmu_2021_741371
crossref_primary_10_1016_j_reval_2013_01_018
crossref_primary_10_1080_13698575_2017_1409887
crossref_primary_10_1093_jpepsy_jsac016
crossref_primary_10_1016_j_jaci_2011_04_036
crossref_primary_10_1016_S2352_4642_20_30234_0
crossref_primary_10_1111_j_1399_3038_2011_01189_x
crossref_primary_10_1517_14712598_8_9_1309
crossref_primary_10_1177_1363459313481234
crossref_primary_10_1080_02739615_2020_1805746
crossref_primary_10_1007_s15007_014_0680_z
crossref_primary_10_1016_j_reval_2013_09_004
crossref_primary_10_3928_00904481_20130619_12
crossref_primary_10_1111_all_12825
crossref_primary_10_1136_archdischild_2014_306152
crossref_primary_10_1016_S0140_6736_08_60659_5
crossref_primary_10_2196_47574
crossref_primary_10_1111_all_12829
crossref_primary_10_1111_j_1398_9995_2006_01303_x
crossref_primary_10_1186_1472_6963_9_142
crossref_primary_10_1016_j_jpeds_2021_10_011
crossref_primary_10_1177_15554120241303322
crossref_primary_10_1007_s11882_016_0614_9
crossref_primary_10_1111_j_1398_9995_2009_02304_x
crossref_primary_10_1016_j_jaci_2019_09_036
crossref_primary_10_1111_j_1399_3038_2009_00859_x
crossref_primary_10_1136_archdischild_2014_306278
crossref_primary_10_1016_j_pop_2023_01_002
crossref_primary_10_1016_j_waojou_2020_100491
crossref_primary_10_1007_s11882_023_01091_0
crossref_primary_10_1186_1472_6955_6_8
crossref_primary_10_1002_clt2_12064
crossref_primary_10_1016_j_mcna_2023_08_003
crossref_primary_10_1097_ACI_0b013e32814a569b
crossref_primary_10_1111_j_1365_2222_2011_03905_x
crossref_primary_10_5934_kjhe_2020_29_3_407
crossref_primary_10_1016_j_jpsychores_2014_10_005
crossref_primary_10_1111_j_1398_9995_2010_02342_x
crossref_primary_10_1053_j_gastro_2015_01_034
crossref_primary_10_3390_children8111050
crossref_primary_10_1111_nhs_12351
crossref_primary_10_1111_all_15312
crossref_primary_10_3389_falgy_2021_810067
crossref_primary_10_1016_j_jaip_2020_12_039
crossref_primary_10_3928_00904481_20130723_14
crossref_primary_10_1111_j_1399_3038_2008_00731_x
crossref_primary_10_1111_j_1365_2222_2011_03699_x
crossref_primary_10_1016_j_childyouth_2022_106436
crossref_primary_10_1016_j_jaci_2022_09_024
crossref_primary_10_1111_cea_13078
crossref_primary_10_1037_cpp0000053
crossref_primary_10_1111_j_1398_9995_2009_02216_x
crossref_primary_10_1016_j_cupe_2005_02_005
crossref_primary_10_1016_j_foodcont_2009_05_008
crossref_primary_10_1016_j_jaip_2015_07_023
crossref_primary_10_1016_j_jaip_2018_10_048
crossref_primary_10_1111_j_1365_2222_2009_03376_x
crossref_primary_10_1186_1710_1492_4_4_144
crossref_primary_10_1097_ACI_0b013e3282ffb168
crossref_primary_10_1542_peds_2015_3678
crossref_primary_10_1111_all_14116
crossref_primary_10_1111_j_1398_9995_2009_01968_x
crossref_primary_10_1016_j_foodcont_2020_107749
crossref_primary_10_1080_13575271003752248
crossref_primary_10_1111_j_1600_065X_2011_01028_x
crossref_primary_10_2217_cpr_14_58
crossref_primary_10_7759_cureus_45114
crossref_primary_10_1016_j_arcped_2006_05_009
crossref_primary_10_1016_j_jaip_2020_12_020
crossref_primary_10_1111_j_1399_3038_2004_00199_x
crossref_primary_10_1186_s13223_020_00443_z
crossref_primary_10_1016_j_jacig_2023_100164
crossref_primary_10_1159_000355199
crossref_primary_10_1080_09540105_2021_1955831
crossref_primary_10_1111_cea_14273
crossref_primary_10_1111_j_1365_2222_2005_02257_x
crossref_primary_10_1016_S0335_7457_07_80013_X
crossref_primary_10_1097_ACI_0b013e32834656c2
crossref_primary_10_1111_pai_12337
crossref_primary_10_1111_all_14363
crossref_primary_10_4236_health_2016_814143
crossref_primary_10_1007_s40629_021_00189_z
crossref_primary_10_1111_pai_13663
crossref_primary_10_1111_j_1539_6924_2010_01488_x
crossref_primary_10_1007_s11882_019_0884_0
crossref_primary_10_1007_s11882_012_0274_3
crossref_primary_10_1080_1744666X_2023_2159812
crossref_primary_10_2500_aap_2021_42_200107
crossref_primary_10_1007_s10880_008_9130_y
crossref_primary_10_3390_nu12092731
crossref_primary_10_1186_s12889_020_09309_w
crossref_primary_10_1080_10410236_2016_1172292
crossref_primary_10_1097_MPG_0000000000001481
crossref_primary_10_1111_j_1399_3038_2008_00801_x
crossref_primary_10_1007_s12016_018_8700_5
crossref_primary_10_1039_C5AN01457C
crossref_primary_10_12688_f1000research_14450_1
crossref_primary_10_1186_1471_2431_8_36
crossref_primary_10_12956_tchd_562419
crossref_primary_10_1056_EVIDe2300223
crossref_primary_10_1080_02739615_2015_1124773
crossref_primary_10_1016_j_jaci_2008_05_015
crossref_primary_10_1111_pai_12569
crossref_primary_10_1111_all_13604
crossref_primary_10_1016_j_perped_2022_10_002
crossref_primary_10_1111_josh_13181
crossref_primary_10_1111_jpc_12794
crossref_primary_10_1111_cea_12599
crossref_primary_10_1111_j_1365_2222_2008_02978_x
crossref_primary_10_1016_j_yrtph_2008_01_002
crossref_primary_10_1111_cea_12113
crossref_primary_10_1111_j_1651_2227_2011_02229_x
crossref_primary_10_1007_s10880_020_09737_1
crossref_primary_10_1172_JCI124605
crossref_primary_10_1016_j_psc_2014_11_004
crossref_primary_10_1111_j_1398_9995_2006_01181_x
crossref_primary_10_1111_j_1365_2222_2010_03649_x
crossref_primary_10_1111_pai_12114
crossref_primary_10_1016_j_xphs_2019_02_022
crossref_primary_10_2147_JAA_S283307
crossref_primary_10_1111_j_1398_9995_2008_01843_x
crossref_primary_10_1111_pai_13443
crossref_primary_10_1111_j_1398_9995_2009_02294_x
crossref_primary_10_1016_j_jaip_2018_07_030
crossref_primary_10_1016_j_jaci_2005_03_039
crossref_primary_10_1016_j_pedhc_2005_10_003
crossref_primary_10_1016_j_jaip_2019_06_037
crossref_primary_10_1146_annurev_med_061014_094943
crossref_primary_10_1080_1744666X_2020_1693264
crossref_primary_10_1111_all_12405
crossref_primary_10_1016_j_jaci_2017_01_040
crossref_primary_10_1016_j_jaci_2018_10_009
crossref_primary_10_1002_alr_22302
crossref_primary_10_1111_j_1399_3038_2008_00765_x
crossref_primary_10_1111_cea_12466
crossref_primary_10_1177_2051013615591739
crossref_primary_10_1155_2016_1497375
crossref_primary_10_1186_s12887_016_0673_z
crossref_primary_10_1111_j_1398_9995_2010_02332_x
crossref_primary_10_4236_fns_2016_710091
crossref_primary_10_1017_S0029665109991832
crossref_primary_10_1111_pai_12105
crossref_primary_10_5409_wjcp_v11_i2_151
crossref_primary_10_1111_j_1399_3038_2007_00517_x
crossref_primary_10_1111_pai_12905
crossref_primary_10_1097_ACI_0b013e32832aa59f
crossref_primary_10_1111_j_1365_2222_2011_03753_x
crossref_primary_10_1111_j_1399_3038_2007_00532_x
crossref_primary_10_1111_j_1399_3038_2012_01341_x
crossref_primary_10_1007_s15007_021_4935_1
crossref_primary_10_1186_1477_7525_4_48
crossref_primary_10_1186_1710_1492_9_7
crossref_primary_10_1111_cea_13548
crossref_primary_10_1002_sscp_201800068
crossref_primary_10_1097_ACI_0b013e328337bd3a
crossref_primary_10_1016_j_iac_2019_07_002
crossref_primary_10_1155_2010_491928
crossref_primary_10_3389_fimmu_2018_02689
crossref_primary_10_1007_s40521_014_0018_9
crossref_primary_10_1016_j_jaci_2009_08_045
crossref_primary_10_1007_s11882_013_0391_7
crossref_primary_10_1111_j_1398_9995_2010_02343_x
crossref_primary_10_1016_j_reval_2016_10_013
crossref_primary_10_1080_1744666X_2016_1226131
crossref_primary_10_1093_tbm_ibz059
crossref_primary_10_1186_s13223_015_0069_x
crossref_primary_10_1111_pai_12099
crossref_primary_10_1007_s15007_024_6250_0
crossref_primary_10_1542_pir_2018_0223
crossref_primary_10_4163_jnh_2018_51_2_140
crossref_primary_10_1111_j_1398_9995_2007_01559_x
crossref_primary_10_1016_j_aller_2016_06_004
crossref_primary_10_1016_j_jada_2010_10_043
crossref_primary_10_1111_cea_12849
crossref_primary_10_12968_indn_2005_1_1_73854
crossref_primary_10_1111_j_1365_2222_2008_03192_x
crossref_primary_10_1111_j_1365_2222_2011_03767_x
crossref_primary_10_1111_cea_12846
crossref_primary_10_1016_j_reval_2020_09_022
crossref_primary_10_1111_all_12427
crossref_primary_10_1111_apa_70016
crossref_primary_10_1016_j_jaci_2009_10_008
crossref_primary_10_1155_2014_372567
crossref_primary_10_1155_2012_316296
crossref_primary_10_3310_eme01040
crossref_primary_10_1111_j_1399_3038_2009_00938_x
crossref_primary_10_1007_s00103_016_2372_1
crossref_primary_10_1016_j_pcl_2015_07_003
crossref_primary_10_1007_s11136_008_9434_2
crossref_primary_10_1016_S1081_1206_10_60908_8
crossref_primary_10_1111_all_15140
crossref_primary_10_28982_josam_778980
crossref_primary_10_1111_j_1399_3038_2006_00455_x
crossref_primary_10_1155_2014_964504
crossref_primary_10_1002_jsfa_6988
crossref_primary_10_1111_sji_12891
crossref_primary_10_1111_j_1468_3083_2010_03858_x
crossref_primary_10_1080_14733285_2013_812273
crossref_primary_10_1016_j_imlet_2005_03_014
crossref_primary_10_1016_j_jaip_2018_06_025
crossref_primary_10_1111_cea_12957
crossref_primary_10_1016_j_jaip_2017_04_016
crossref_primary_10_1111_pai_12528
crossref_primary_10_1111_j_1365_2222_2008_03120_x
crossref_primary_10_1007_s12026_010_8183_9
crossref_primary_10_1016_j_jaci_2009_04_004
crossref_primary_10_1111_j_1399_3038_2008_00796_x
crossref_primary_10_1111_all_15709
crossref_primary_10_1136_bmjpo_2023_002294
crossref_primary_10_1111_j_1399_3038_2010_01043_x
crossref_primary_10_1111_j_1440_1754_2004_00509_x
crossref_primary_10_3390_children9081192
crossref_primary_10_1016_j_jaci_2006_04_024
crossref_primary_10_1016_j_waojou_2021_100512
crossref_primary_10_1016_j_yrtph_2018_09_020
crossref_primary_10_1542_peds_2019_2102
crossref_primary_10_1016_j_anai_2020_03_028
crossref_primary_10_1111_j_1365_2222_2008_03010_x
crossref_primary_10_1016_j_reval_2023_103345
crossref_primary_10_1111_j_1399_3038_2010_01005_x
crossref_primary_10_1155_2012_269376
crossref_primary_10_1097_01_NT_0000303306_01224_69
crossref_primary_10_1007_s11882_009_0027_0
crossref_primary_10_1016_j_tifs_2010_09_004
crossref_primary_10_1111_j_1365_2222_2010_03554_x
crossref_primary_10_1016_S1877_0320_22_00489_4
crossref_primary_10_1111_all_13095
crossref_primary_10_1016_j_anai_2019_12_021
crossref_primary_10_1016_j_jaip_2012_10_009
crossref_primary_10_1016_j_jaci_2006_12_670
crossref_primary_10_1111_pai_12437
crossref_primary_10_1136_bmjopen_2012_001282
crossref_primary_10_1016_j_jaip_2020_08_015
crossref_primary_10_1111_jpc_12166
crossref_primary_10_1016_j_anai_2014_06_027
crossref_primary_10_1111_cea_12940
crossref_primary_10_1186_1471_2431_13_203
crossref_primary_10_1016_j_reval_2012_01_020
crossref_primary_10_1111_j_1399_3038_2009_00975_x
crossref_primary_10_1016_S0140_6736_04_16996_1
crossref_primary_10_1111_cea_13111
crossref_primary_10_1016_j_arcped_2005_02_031
crossref_primary_10_1038_nrdp_2017_98
crossref_primary_10_1016_j_anai_2010_08_009
crossref_primary_10_1177_183693911604100414
crossref_primary_10_1016_j_jpp_2023_09_006
crossref_primary_10_1093_jpepsy_jsv009
crossref_primary_10_1177_1367493509359227
crossref_primary_10_1016_j_jaip_2018_11_005
crossref_primary_10_1186_1710_1492_10_25
crossref_primary_10_1016_j_anai_2010_09_030
crossref_primary_10_1111_all_14871
crossref_primary_10_1007_s10620_006_3157_4
crossref_primary_10_1016_j_pedn_2018_04_009
crossref_primary_10_1016_j_allerg_2005_12_005
crossref_primary_10_1111_j_1651_2227_2004_tb03014_x
crossref_primary_10_1097_MOP_0b013e32833f5fc0
crossref_primary_10_1016_S0140_6736_13_62301_6
crossref_primary_10_1016_j_anai_2010_08_003
crossref_primary_10_1093_immadv_ltac006
crossref_primary_10_1111_j_1398_9995_2011_02766_x
crossref_primary_10_1016_j_fct_2006_09_005
Cites_doi 10.1016/S1081-1206(10)62258-2
10.1016/S0140-6736(00)04687-0
10.1067/mai.2002.120552
10.1002/pdi.1960140205
10.1046/j.1365-2222.2000.00864.x
10.1016/S1081-1206(10)62543-4
10.1097/00130832-200206000-00012
10.1067/mpd.2000.109376
10.1067/mai.2002.125827
10.1067/mai.2001.115755
10.1046/j.1365-2222.2000.00889.x
10.1067/mai.2001.112031
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright_xml – notice: 2004 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.1034/j.1399-3038.2003.00072.x
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3038
EndPage 382
ExternalDocumentID 14641608
15230607
10_1034_j_1399_3038_2003_00072_x
PAI072
ark_67375_WNG_PCL8KL5R_T
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
29O
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESTFP
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J8S
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACUHS
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
ID FETCH-LOGICAL-c4632-f1a666e245ab1273fba59104accacdf79071e475b0ce011b22d95f83ca9a65aa3
IEDL.DBID DR2
ISSN 0905-6157
IngestDate Fri Jul 11 13:06:10 EDT 2025
Thu Jul 10 21:37:02 EDT 2025
Wed Feb 19 01:51:55 EST 2025
Mon Jul 21 09:12:54 EDT 2025
Tue Jul 01 01:25:11 EDT 2025
Thu Apr 24 23:03:35 EDT 2025
Wed Jan 22 16:33:02 EST 2025
Wed Oct 30 09:57:33 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Allergy
Peanut
Immunopathology
Pediatrics
peanut allergy
Immunology
children
Quality control
Child
Quality of life
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4632-f1a666e245ab1273fba59104accacdf79071e475b0ce011b22d95f83ca9a65aa3
Notes istex:0E70B0A34E0D4A1A42CBDE7989E6B58238922427
ark:/67375/WNG-PCL8KL5R-T
ArticleID:PAI072
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 14641608
PQID 19434387
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_71414464
proquest_miscellaneous_19434387
pubmed_primary_14641608
pascalfrancis_primary_15230607
crossref_citationtrail_10_1034_j_1399_3038_2003_00072_x
crossref_primary_10_1034_j_1399_3038_2003_00072_x
wiley_primary_10_1034_j_1399_3038_2003_00072_x_PAI072
istex_primary_ark_67375_WNG_PCL8KL5R_T
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2003
PublicationDateYYYYMMDD 2003-10-01
PublicationDate_xml – month: 10
  year: 2003
  text: October 2003
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle Pediatric allergy and immunology
PublicationTitleAlternate Pediatr Allergy Immunol
PublicationYear 2003
Publisher Munksgaard International Publishers
Blackwell
Publisher_xml – name: Munksgaard International Publishers
– name: Blackwell
References Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002: 110: 174-82.
Vander Leek T, Liu A, Stefanski K, Blacker B, Allan Bock S. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Paediatr 2000: 137: 749-55.
Thompson A, Juniper E, Meltzer E. 'Quality of life in patients with allergic rhinitis'. Ann Allergy, Asthma Immunol 2000: 85: 338-44.
Gardiner P. Social and psychological implications of diabetes mellitus for a group of adolescents. Pract Diabetes Int 1997: 14: 43-6.
Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001: 107: 191-3.
McCabe M, Lyons RA, Hodgson P, Griffiths G, Jones R. Management of peanut allergy. Lancet 2001: 357: 1531-2.
Sicherer S, Noone S, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy, Asthma Immunol 2001: 87: 461-4.
Oude Elberink JN, De Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002: 109: 162-70.
Primeau M, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000: 30: 1135-43.
Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001: 108: 128-32.
Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000: 30: 1144-50.
Hourihane JO'B. Recent advances in peanut allergy. Curr Opin Allergy Clin Immunology 2002: 2: 227-31.
2002; 2
2002; 109
2001; 108
2001; 107
2002; 110
2000; 137
2001; 357
1997; 14
2000; 30
2000; 85
2001; 87
e_1_2_12_3_2
e_1_2_12_2_2
e_1_2_12_5_2
e_1_2_12_4_2
Oude Elberink JN (e_1_2_12_8_2) 2002; 109
e_1_2_12_13_2
e_1_2_12_12_2
e_1_2_12_11_2
e_1_2_12_7_2
e_1_2_12_10_2
e_1_2_12_6_2
e_1_2_12_9_2
References_xml – reference: Thompson A, Juniper E, Meltzer E. 'Quality of life in patients with allergic rhinitis'. Ann Allergy, Asthma Immunol 2000: 85: 338-44.
– reference: Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000: 30: 1144-50.
– reference: Vander Leek T, Liu A, Stefanski K, Blacker B, Allan Bock S. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Paediatr 2000: 137: 749-55.
– reference: Hourihane JO'B. Recent advances in peanut allergy. Curr Opin Allergy Clin Immunology 2002: 2: 227-31.
– reference: Gardiner P. Social and psychological implications of diabetes mellitus for a group of adolescents. Pract Diabetes Int 1997: 14: 43-6.
– reference: Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001: 107: 191-3.
– reference: Sicherer S, Noone S, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy, Asthma Immunol 2001: 87: 461-4.
– reference: Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001: 108: 128-32.
– reference: Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002: 110: 174-82.
– reference: McCabe M, Lyons RA, Hodgson P, Griffiths G, Jones R. Management of peanut allergy. Lancet 2001: 357: 1531-2.
– reference: Primeau M, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000: 30: 1135-43.
– reference: Oude Elberink JN, De Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002: 109: 162-70.
– volume: 108
  start-page: 128
  year: 2001
  end-page: 32
  article-title: A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants
  publication-title: J Allergy Clin Immunol
– volume: 110
  start-page: 174
  year: 2002
  end-page: 82
  article-title: Venom immunotherapy improves health‐related quality of life in patients allergic to yellow jacket venom
  publication-title: J Allergy Clin Immunol
– volume: 109
  start-page: 162
  year: 2002
  end-page: 70
  article-title: Development and validation of a health‐related quality‐of‐life questionnaire in patients with yellow jacket allergy
  publication-title: J Allergy Clin Immunol
– volume: 137
  start-page: 749
  year: 2000
  end-page: 55
  article-title: The natural history of peanut allergy in young children and its association with serum peanut‐specific IgE
  publication-title: J Paediatr
– volume: 2
  start-page: 227
  year: 2002
  end-page: 31
  article-title: Recent advances in peanut allergy
  publication-title: Curr Opin Allergy Clin Immunology
– volume: 14
  start-page: 43
  year: 1997
  end-page: 6
  article-title: Social and psychological implications of diabetes mellitus for a group of adolescents
  publication-title: Pract Diabetes Int
– volume: 87
  start-page: 461
  year: 2001
  end-page: 4
  article-title: The impact of childhood food allergy on quality of life
  publication-title: Ann Allergy, Asthma Immunol
– volume: 85
  start-page: 338
  year: 2000
  end-page: 44
  article-title: ‘Quality of life in patients with allergic rhinitis’
  publication-title: Ann Allergy, Asthma Immunol
– volume: 107
  start-page: 191
  year: 2001
  end-page: 3
  article-title: Fatalities due to anaphylactic reactions to foods.
  publication-title: J Allergy Clin Immunol
– volume: 30
  start-page: 1144
  year: 2000
  end-page: 50
  article-title: Lessons for management of anaphylaxis from a study of fatal reactions
  publication-title: Clin Exp Allergy
– volume: 357
  start-page: 1531
  year: 2001
  end-page: 2
  article-title: Management of peanut allergy
  publication-title: Lancet
– volume: 30
  start-page: 1135
  year: 2000
  end-page: 43
  article-title: The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut‐allergic children
  publication-title: Clin Exp Allergy
– ident: e_1_2_12_7_2
  doi: 10.1016/S1081-1206(10)62258-2
– ident: e_1_2_12_5_2
  doi: 10.1016/S0140-6736(00)04687-0
– volume: 109
  start-page: 162
  year: 2002
  ident: e_1_2_12_8_2
  article-title: Development and validation of a health‐related quality‐of‐life questionnaire in patients with yellow jacket allergy
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2002.120552
– ident: e_1_2_12_12_2
  doi: 10.1002/pdi.1960140205
– ident: e_1_2_12_4_2
  doi: 10.1046/j.1365-2222.2000.00864.x
– ident: e_1_2_12_11_2
  doi: 10.1016/S1081-1206(10)62543-4
– ident: e_1_2_12_10_2
  doi: 10.1097/00130832-200206000-00012
– ident: e_1_2_12_3_2
  doi: 10.1067/mpd.2000.109376
– ident: e_1_2_12_9_2
  doi: 10.1067/mai.2002.125827
– ident: e_1_2_12_13_2
  doi: 10.1067/mai.2001.115755
– ident: e_1_2_12_6_2
  doi: 10.1046/j.1365-2222.2000.00889.x
– ident: e_1_2_12_2_2
  doi: 10.1067/mai.2001.112031
SSID ssj0017361
Score 2.2507598
Snippet Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which...
Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 378
SubjectTerms Activities of Daily Living
Anxiety - epidemiology
Anxiety - psychology
Arachis hypogaea
Biological and medical sciences
Child
Child Welfare
children
Diabetes Mellitus, Type 1 - epidemiology
Diabetes Mellitus, Type 1 - psychology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
General aspects
Humans
Male
Medical sciences
peanut allergy
Peanut Hypersensitivity - epidemiology
Peanut Hypersensitivity - psychology
Photography
quality of life
Quality of Life - psychology
Restaurants
Risk Factors
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Sickness Impact Profile
Surveys and Questionnaires
Title Assessment of quality of life in children with peanut allergy
URI https://api.istex.fr/ark:/67375/WNG-PCL8KL5R-T/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1034%2Fj.1399-3038.2003.00072.x
https://www.ncbi.nlm.nih.gov/pubmed/14641608
https://www.proquest.com/docview/19434387
https://www.proquest.com/docview/71414464
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9QwDLfQJiFe-P7oBkcfEG89mq-m93gbHAO2aZo2sbcoaRM03dRD9yFt_PXYae9OhwBNiLeoalLVsWM7tn8GeMN90KGu88wSDIAsAstcVeYZaipUXoLndSwfOzouDs7l5wt10eU_US1Miw-xunAjyYjnNQm4dbOuTFy2Qo7KNcMjuIywnoREqHmf7ElK3SL76HSFJMW0iNCp-SBX6C0p3SX14FLv_rTQhqbaJqJfU-aknSHxQtv14ndm6aaVG9XU6AGMlz_YZqeM-4u561c_fsF-_D8UeAj3O2s2Hbbs9wju-OYx3D3q4vVPoIsp0w1kOglpW8F5Q8Ory-DTyyZdFpOndCGcUlxgMU-pv8v0281TOB99ONs_yLqGDVklC8GzwCx6Q55LZR1Duyg4q9AckRbZpKqDRkeceamVyyuP54rjvB6oUIrKDmyhrBXPYKuZNP4FpAS6Q66VK4KTleNO-yIXtsKVuasZT0AvN8dUHZo5NdW4MjGqLiR5NUgdQ9ShXpvCROqY6wTYaub3FtHjFnPexv1fTbDTMWXEaWW-Hn80J_uH5ZdDdWrOEuhtMMj6C3T7XuQ6gddLjjEoyBSdsY2fLGaGEVKfKP_yhmaSvHeZwPOW1dar41NW5GUCKjLMrX_MnAw_4WDnH-ftwr11cuNL2JpPF_4VGmlz14Pt4d77vVEviuFPrkUreA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swED9GC9te9v3hbm39MPbmzJIly3ksZW26JqGUlPVNSLZUSoMz0gTa_vW7k52EjK2UsjdjLBmf73TfvwP4wp1XvqrSxBAMgMg9S2xZpAlqKlReGU-r0D42GOa9M_HjXJ6344CoF6bBh1gG3EgywnlNAk4B6bZPXDRSjto1wTO4CLieBEWoeAcNyk0a8B38q9MllhRTWQBPTbupRH9JqrasB_f69q-d1nTVJpH9hmonzTWSzzdzL_5mmK7buUFRHbyE8eITm_qUq858Zjvl3R_oj_-JBq_gRWvQxnsNB76GJ65-A08Hbcr-LbRpZQpCxhMfN02ct3Q5vvQuvqzjRT95TDHhmFID81lMI16mF7fv4Ozg-2i_l7QzG5JS5BlPPDPoEDkupLEMTSNvjUSLRBjklLLyCn1x5oSSNi0dHi2W86orfZGVpmtyaUz2HjbqSe0-Qky4O-Rd2dxbUVpulcvTzJS4M7cV4xGoxd_RZQtoTnM1xjok1jNBjg1SRxN1aNxmpgN19E0EbLnyVwPq8YA1XwMDLBeY6RUVxSmpfw4P9cl-vzjuy1M9imBnjUNWb6AAfJ6qCHYXLKNRlilBY2o3mV9rRmB9WXHPE4oJcuBFBB8aXlvtjndZnhYRyMAxD_4wfbJ3hBdbj1y3C896o0Ff94-Gx5_g-arW8TNszKZzt40228zuBFn8Df3vLiE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NIKG97PsjY4M8THtLFzt2nD4iWIFRqgqBxptlJ_aEilJUWgn463fnpK06AULT3qwodpTzne_Od_c7gK_ceeWrKk0MwQCI3LPElkWaoKZC5ZXxtArlY8eD_OBM_DyX523-E9XCNPgQiws3koxwXpOAX1W-LRMXjZCjck3wCC4CrCchESreQXtyXeRpQRy-d7KAkmIqC9ipaTeV6C5J1Wb14FrfH1ppRVWtE9VvKHXSXCP1fNP24j67dNXMDXqq9xJG8z9s0lNGndnUdsq7v8Af_w8JXsGL1pyNdxr-ew3PXP0GNo7bgP1baIPKdAUZj33clHDe0vDywrv4oo7n1eQx3QjHFBiYTWNq8DL5ffsOzno_TncPkrZjQ1KKPOOJZwbdIceFNJahYeStkWiPCIN8UlZeoSfOnFDSpqXDg8VyXnWlL7LSdE0ujcnew1o9rt1HiAl1h3wrm3srSsutcnmamRJX5rZiPAI13xxdtnDm1FXjUoeweibIrUHqaKIONdvMdKCOvomALWZeNZAeT5jzLez_YoKZjCglTkn9a7Cvh7v94qgvT_RpBFsrDLL8Al2_56mKYHvOMRolmcIzpnbj2bVmBNWXFY-8oZgg911E8KFhteXq-JQh10cgA8M8-cf0cOcQB5_-cd42bAz3erp_ODjahOfLRMfPsDadzNwXNNimditI4h9W0izZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+quality+of+life+in+children+with+peanut+allergy&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Avery%2C+Natalie+J.&rft.au=King%2C+Rosemary+M.&rft.au=Knight%2C+Susan&rft.au=Hourihane%2C+Jonathan+O%27B.&rft.date=2003-10-01&rft.issn=0905-6157&rft.eissn=1399-3038&rft.volume=14&rft.issue=5&rft.spage=378&rft.epage=382&rft_id=info:doi/10.1034%2Fj.1399-3038.2003.00072.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1034_j_1399_3038_2003_00072_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon